BHI
logo
  • Health Plans
    • Transparency Analytics
    • Plan Performance Analytics
    • Provider Analytics
    • Employer Analytics
    • Health Equity
    • Risk Adjustment
  • Real-World Evidence Generation
  • Resources
  • About
    • Company
    • Leadership
  • Careers
  • Contact Us
  • Subscribe

JUST RELEASED

Real-World Trends in GLP-1 Prescribing and Treatment Persistence for Weight Management

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Read the Issue Brief

Sign up to receive updates from BHI

Subscribe
Hide filtersShow filters
× Close
  • Benchmarking
  • Boost Your Skills
  • COVID-19
  • Chronic disease management
  • Episode of Care Grouper
  • HITRUST
  • National Benchmarking
  • Physician performance
  • Population Advyzer
  • Predictive analytics
  • Prescription drugs
  • Price transparency
  • QE
  • REL data
  • Real-world data (RWD)
  • Risk Adjustment
  • Risk scoring
  • Transparency Analytics
  • artificial intelligence
  • behavioral health
  • cost transparency
  • employer analytics and reporting
  • health equity
  • hospital outpatient care
  • machine learning
  • medical device
  • real-world evidence (RWE)
  • site-neutral
  • telehealth
  • value-based care
  • whyzen analytics

Clear all Apply

Reports

2024 QE Report: Use of Imaging Studies for Low Back Pain, 2017-2022

Reports

Real-World Trends in GLP-1 Prescribing and Treatment Persistence for Weight Management

Reports

Hospital Outpatient Prices Far Higher, Rising Faster than Physician Sites

Reports

2023 QE Report: Use of Imaging Studies for Low Back Pain, 2017-2021

Webinars

Create Custom Metrics, Explore the Dynamic High-Cost Claimant Indicator

News

Costs for Common Health Care Procedures Significantly Higher When Performed in Hospital Outpatient Departments

Reports

Rising Prices for Hospital Outpatient Care Far Outpace More Affordable Sites

Blog

5 Key Indicators of Real-World Data Quality

Blog

3 Key Themes from ISPOR 2023

  • 1
  • 2
  • 3
  • …
  • 7

© 2024 Blue Health Intelligence. Blue Health Intelligence (BHI) is a trade name of Health Intelligence Company LLC, an independent licensee of the Blue Cross Blue Shield Association.

Privacy Preference Center

Privacy Preferences